There were 1,710 press releases posted in the last 24 hours and 402,596 in the last 365 days.

Janssen to reveal current findings from recent ADEPT study at Asthma & COPD 2015

SMi’s 11th annual Asthma & COPD conference will take place on the 13th & 14th April 2015 at the Holiday Inn, Regents Park Hotel in London UK

LONDON, ENGLAND, UNITED KINGDOM, January 13, 2015 /EINPresswire.com/ -- It was announced last week that Vectura will be entering into a partnership with Janssen to develop therapies for Asthma and COPD. Janssen will lead the clinical development programmes with Vectura taking responsibility for pharmaceutical growth and preparation for Phase II trials.*

Hear more from Janssen at SMi's 11th annual Asthma & COPD when the sell-out show returns to London on 13th & 14th April.

Immunology and Pulmonary Disease Director, Philip E Silkoff will be providing this year’s attendees with an exclusive insight into the ADEPT study in a presentation entitled: Airways disease endotyping for personalised therapeutics in asthma & COPD. The address will analyse results from the trial and discuss current and future therapeutic targets. For further information visit http://www.smi-online.co.uk/goto/2015asthma-copd38.asp

Other key speakers will include: Imperial College London, University of Glasgow, Genetech, MedImmune, GSK, Verona Pharma, plus many more.

A brochure is available to download at http://www.smi-online.co.uk/goto/2015asthma-copd38.asp

Sponsored by Artimmune S.A.S

For those who are interested in attending there is currently a £200 discount available online. Visit http://www.smi-online.co.uk/goto/2015asthma-copd38.asp

*Source: http://www.pharmafile.com/news/197131/vectura-and-jj-shake-asthmacopd-deal

-------------------------- END --------------------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group Ltd
+44 (0) 20 7827 6162
email us here